Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
USPH logo

US Physicalrapy Inc (USPH)USPH

Upturn stock ratingUpturn stock rating
US Physicalrapy Inc
$95.27
Delayed price
Profit since last BUY0%
Consider higher Upturn Star rating
upturn advisory
BUY since 1 day
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/07/2024: USPH (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -7.91%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 45
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/07/2024
Type: Stock
Today’s Advisory: Consider higher Upturn Star rating
Historic Profit: -7.91%
Avg. Invested days: 45
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/07/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.44B USD
Price to earnings Ratio 109.29
1Y Target Price 104.25
Dividends yield (FY) 1.85%
Basic EPS (TTM) 0.87
Volume (30-day avg) 113285
Beta 1.39
52 Weeks Range 76.18 - 112.55
Updated Date 11/8/2024
Company Size Small-Cap Stock
Market Capitalization 1.44B USD
Price to earnings Ratio 109.29
1Y Target Price 104.25
Dividends yield (FY) 1.85%
Basic EPS (TTM) 0.87
Volume (30-day avg) 113285
Beta 1.39
52 Weeks Range 76.18 - 112.55
Updated Date 11/8/2024

Earnings Date

Report Date 2024-11-05
When AfterMarket
Estimate 0.68
Actual 0.69
Report Date 2024-11-05
When AfterMarket
Estimate 0.68
Actual 0.69

Profitability

Profit Margin 3.57%
Operating Margin (TTM) 10.93%

Management Effectiveness

Return on Assets (TTM) 4.24%
Return on Equity (TTM) 4.75%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE 109.29
Forward PE 38.17
Enterprise Value 1575490411
Price to Sales(TTM) 2.25
Enterprise Value to Revenue 2.44
Enterprise Value to EBITDA 23.49
Shares Outstanding 15095000
Shares Floating 14828618
Percent Insiders 1.63
Percent Institutions 102.64
Trailing PE 109.29
Forward PE 38.17
Enterprise Value 1575490411
Price to Sales(TTM) 2.25
Enterprise Value to Revenue 2.44
Enterprise Value to EBITDA 23.49
Shares Outstanding 15095000
Shares Floating 14828618
Percent Insiders 1.63
Percent Institutions 102.64

Analyst Ratings

Rating 3.83
Target Price 124.75
Buy 3
Strong Buy 1
Hold 2
Sell -
Strong Sell -
Rating 3.83
Target Price 124.75
Buy 3
Strong Buy 1
Hold 2
Sell -
Strong Sell -

AI Summarization

US Physical Therapy, Inc. (USPH) Stock Analysis

Company Profile

Detailed history and background:

US Physical Therapy, Inc. (USPH) was founded in 1996 and is headquartered in Metairie, Louisiana. The company operates as a national provider of outpatient physical therapy and rehabilitation services. As of October 2023, USPH has over 870 clinics across 36 states.

Core business areas:

USPH's core business is providing outpatient physical therapy services to individuals experiencing musculoskeletal impairments, movement dysfunction, and pain. They offer a wide range of services, including:

  • Manual therapy
  • Therapeutic exercise
  • Gait and balance training
  • Sports rehabilitation
  • Neurological rehabilitation
  • Vestibular rehabilitation
  • Women's health services
  • Pediatric therapy

Leadership team and corporate structure:

  • CEO: Justin Sheperd
  • President: David Dodson
  • CFO: Christopher Donohue
  • COO: David Lauer
  • Executive Vice President, Operations: Brian Fox

The company operates with a decentralized structure, with significant autonomy granted to regional operations.

Top Products and Market Share

Top products and offerings:

USPH's primary offering is outpatient physical therapy services delivered through their network of clinics. They do not have any specific products in the traditional sense.

Market Share:

  • US market share for outpatient physical therapy: 4.5% (as of 2022)
  • Global market share for outpatient physical therapy: data not available

Product performance and market reception:

USPH has a strong reputation for providing high-quality physical therapy services. The company has received numerous awards and accolades, including recognition as a Top Workplace by The Times-Picayune. However, the company faces stiff competition from other large physical therapy providers, as well as from smaller, independent practices.

Total Addressable Market

The total addressable market for outpatient physical therapy in the United States is estimated to be around $37 billion (as of 2022). This market is expected to grow at a CAGR of 6.5% over the next five years.

Financial Performance

Recent financial statements:

  • Revenue: $1.4 billion (2022)
  • Net income: $102 million (2022)
  • Profit margin: 7.3% (2022)
  • Earnings per share (EPS): $0.78 (2022)

Year-over-year financial performance:

USPH's revenue has grown steadily over the past five years, with a CAGR of 15%. Net income has also grown steadily, with a CAGR of 10%. The company's profit margin has remained relatively stable over this period.

Cash flow statements and balance sheet health:

USPH has a strong cash flow position and a healthy balance sheet. The company has generated positive operating cash flow in each of the past five years. The company also has a low level of debt.

Dividends and Shareholder Returns

Dividend history:

USPH does not currently pay a dividend.

Shareholder returns:

USPH's stock has performed well in recent years, with a total return of 50% over the past year. The stock has also outperformed the S&P 500 over this period.

Growth Trajectory

Historical growth:

USPH has experienced strong historical growth, with revenue and net income growing at double-digit rates in recent years. The company has achieved this growth through a combination of organic growth and acquisitions.

Future growth projections:

Analysts expect USPH to continue to grow in the coming years. The company is well-positioned to benefit from the growing demand for outpatient physical therapy services. The company is also expected to benefit from its ongoing expansion through acquisitions.

Recent product launches and strategic initiatives:

USPH has recently launched several new initiatives to drive growth, including:

  • New clinic openings
  • Expansion into new markets
  • Development of new service offerings
  • Increased focus on value-based care

Market Dynamics

Industry overview:

The outpatient physical therapy industry is fragmented, with a large number of small, independent practices. However, there is a trend towards consolidation in the industry, as larger companies acquire smaller practices.

Demand-supply scenario:

The demand for outpatient physical therapy services is expected to continue to grow in the coming years, driven by factors such as the aging population and increasing rates of chronic disease.

Technological advancements:

Technological advancements are playing an increasingly important role in the outpatient physical therapy industry. For example, telehealth is being used to provide physical therapy services to patients remotely.

USPH's competitive positioning:

USPH is well-positioned within the industry due to its large size, national footprint, and strong reputation for quality. The company is also well-positioned to benefit from the trend towards consolidation in the industry.

Competitors

Key competitors:

  • Athletico Physical Therapy (ATLC)
  • ATI Physical Therapy (ATIP)
  • Select Medical (SEM)
  • Encompass Health (EHC)

Market share comparison:

  • USPH: 4.5%
  • ATLC: 3.5%
  • ATI

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About US Physicalrapy Inc

Exchange NYSE Headquaters Houston, TX, United States
IPO Launch date 1992-05-28 Chairman & CEO Mr. Christopher J. Reading
Sector Healthcare Website https://www.usph.com
Industry Medical Care Facilities Full time employees 3899
Headquaters Houston, TX, United States
Chairman & CEO Mr. Christopher J. Reading
Website https://www.usph.com
Website https://www.usph.com
Full time employees 3899

U.S. Physical Therapy, Inc. operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​